EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel Autologous Regulatory T-Cell Therapy Ameliorates DSS-Induced Colitis in Humanized Mice

Md Jabed Khan iD, Yoo Jin Lee, Su Yeon Lee, Hyeyeon Chung, Thuy Nguyen-Phuong, Yong-Hee Kim, Chung-Gyu Park, Young Mo Kang iD

Inflammatory Bowel Diseases · 01.09.2025 · 31 (9) · 2535-2546

DOI: 10.1093/ibd/izaf141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 07.07.2025. Verfasst von Md Jabed Khan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Preclina Inc., 719 & 1302, Teratower B, 167, Songpa-daero, Songpa-gu, Seoul, South Korea. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Colitis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and ICT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inflammatory bowel disease (IBD) is a chronic inflammatory disorder with a complex immune-mediated pathogenesis. The efficacy of human-specific cellular immunotherapies and biological medications cannot be accurately evaluated using traditional murine IBD models. Therefore, a humanized mouse model of IBD is necessary. Regulatory T cells (Tregs) are critical for maintaining intestinal immune homeostasis and may have therapeutic potential for treating IBD.

Methods

Donor peripheral blood mononuclear cells (PBMCs) were used to reconstitute the human immune system in NOG mice and for Treg isolation. T cells were sorted and stimulated with anti-CD3 and anti-CD28 in the presence of irradiated feeder cells to prepare Treg cells. Two weeks after PBMC reconstitution in NOG mice, colitis was induced with dextran sodium sulfate (DSS). The expanded Treg cells were administered intravenously. Ozanimod was used as a positive control.

Results

After expansion, 65.4% of the live CD4+ cells were Foxp3+CD25+ Treg cells and 14.5% were non-Treg cells. The mean human leukocyte (hCD45+) engraftment rate in the humanized mice was 56.5% ± 4.5%. Autologous Treg-cell therapy significantly reduced the disease activity index by 78% on day 7. Colonic length was preserved, and colonic inflammation was reduced in mice treated with Treg cells. Immunohistology revealed reduced human T-cell infiltration in Treg-treated mice.

Conclusions

Autologous Treg therapy ameliorated the symptoms of DSS-induced colitis in a humanized mouse model. The autologous PBMC-humanized DSS-induced colitis model may serve as a robust preclinical platform for evaluating the efficacy of personalized Treg cell therapy for IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Lymphocytes, RegulatoryColitisAnimalsMiceHumansDextran SulfateDisease Models, AnimalTransplantation, AutologousLeukocytes, Mononuclear

Stichwörter der Autor:innen

autologous treg therapydextran sodium sulfate colitishumanized miceinflammatory bowel diseasepreclinical modelregulatory T cells

Substanzen

Dextran Sulfate

Autor:innen und Institutionen

  • Preclina Inc., 719 & 1302, Teratower B, 167, Songpa-daero, Songpa-gu, Seoul, South Korea.
  • Division of Rheumatology, Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, South Korea.
  • Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul, South Korea.
  • Transplantation Research Institute, Medical Research Center, Seoul National University, Seoul, South Korea.
  • Department of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul, South Korea.
  • Cancer Research Institute, Seoul National University, Seoul, South Korea.

ORCID-Profile: Md Jabed Khan, Young Mo Kang

Förderung

  • Ministry of Science and ICT

Zitieren

APA

Khan, M. J., Lee, Y. J., Lee, S. Y., Chung, H., Nguyen-Phuong, T., Kim, Y. H., Park, C. G., & Kang, Y. M. (2025). Novel Autologous Regulatory T-Cell Therapy Ameliorates DSS-Induced Colitis in Humanized Mice. Inflammatory Bowel Diseases, 31(9), 2535-2546. https://doi.org/10.1093/ibd/izaf141

Vancouver

Khan MJ, Lee YJ, Lee SY, Chung H, Nguyen-Phuong T, Kim YH, et al. Novel Autologous Regulatory T-Cell Therapy Ameliorates DSS-Induced Colitis in Humanized Mice. Inflammatory Bowel Diseases. 2025;31(9):2535-2546. doi:10.1093/ibd/izaf141

BibTeX
@article{Khan2025,
  author = {Khan, Md Jabed and Lee, Yoo Jin and Lee, Su Yeon and Chung, Hyeyeon and Nguyen-Phuong, Thuy and Kim, Yong-Hee and Park, Chung-Gyu and Kang, Young Mo},
  title = {Novel Autologous Regulatory T-Cell Therapy Ameliorates DSS-Induced Colitis in Humanized Mice},
  journal = {Inflammatory Bowel Diseases},
  year = {2025},
  volume = {31},
  number = {9},
  pages = {2535--2546},
  doi = {10.1093/ibd/izaf141}
}
Kostenlos starten →